$コディアック サイエンシズ(KOD.US)$ NEWS Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform
$コディアック サイエンシズ(KOD.US)$announced first time results of KSI-501 ABC Phase 1 study. The data outlined safety and biocativity of KSI-501, along with high binding affinity and bioactivity against VEGF and IL-6.
While Kodiak Sciences' cash runway is reassuring, its cash burn relative to its market cap is concerning. The company's high expenditure relative to its market value suggests an elevated risk of funding distress, making the stock a risky investment.
- 📈 Dow Jones extends its winning streak to six sessions, the longest since late July. - 🇺🇸 U.S. stocks had their best week of 2023. - 💹 Dow Jones gained 0.1%, the S&P 500 rose 0.2%, and the Nasdaq Composite was up 0.3%. - 📅 Monday marked the Nasdaq's seventh consecutive day of gains, matching a win streak last seen in January. - 📊 Last week saw significant gains, with the Dow Jones up 5.1%, the S&P 500 up 5.9%, and the Nasdaq Composite up 6.6%. - 📉 Bond yields tempo...
$コディアック サイエンシズ(KOD.US)$announces one-year topline data for its ABC Platform based investigational therapy tarcocimab tedromer from the pivotal BEACON study in patients with macular edema due to retinal vein occlusion (RVO)
$コディアック サイエンシズ(KOD.US)$I get the bad news yesterday,but surely they have more than that trail going on.I bought yesterday and of drops probably buy more because my opinion to oversold not to own some
コディアック サイエンシズに関するコメント
NEWS
Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform
$アイポイント ファーマシューティカルズ(EYPT.US)$
$アドベラム バイオテクノロジーズ(ADVM.US)$
$リジェネックスバイオ(RGNX.US)$
$4D モレキュラー セラピューティクス(FDMT.US)$
$コディアック サイエンシズ(KOD.US)$
- 🇺🇸 U.S. stocks had their best week of 2023.
- 💹 Dow Jones gained 0.1%, the S&P 500 rose 0.2%, and the Nasdaq Composite was up 0.3%.
- 📅 Monday marked the Nasdaq's seventh consecutive day of gains, matching a win streak last seen in January.
- 📊 Last week saw significant gains, with the Dow Jones up 5.1%, the S&P 500 up 5.9%, and the Nasdaq Composite up 6.6%.
- 📉 Bond yields tempo...
$アトランティカ サステナブル インフラ(AY.US)$ $エディソン・ネーション(BBIG.US)$ $ベクトン ディッキンソン(BDX.US)$ $ブルージェイ ダイアグノースティスス(BJDX.US)$ $F5 インク(FFIV.US)$ $ヘクセル(HXL.US)$ $インテューイティブ サージカル(ISRG.US)$ $コディアック サイエンシズ(KOD.US)$ $コス コーポレーシヨン(KOSS.US)$ $マーカー セラピューティクス(MRKR.US)$ $ニューロワン メディカル テクノロジーズ(NMTC.US)$ $NXP セミコンダクターズ(NXPI.US)$ $RLI(RLI.US)$ $タッパーウェア ブランズ(TUP.US)$ $ワールプール(WHR.US)$ $エクスピオン360(XPON.US)$
まだコメントはありません